Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | PPARG | P37231 | 2/20 | 0.51 |
| ▸ | PPARA | Q07869 | 1/20 | 0.48 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | POLA1 | P09884 | 1/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | DGKA | P23743 | 1/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15964153 | 0.95 | MEN1 (0.57) | MEN1KMT2AL3MBTL1PPARGPPARA | |
| SCHEMBL1985687 | 0.95 | MEN1 (0.57) | MEN1KMT2AL3MBTL1PPARGPPARA | |
| SCHEMBL17690438 | 0.95 | MEN1 (0.57) | MEN1KMT2AL3MBTL1PPARGPPARA | |
| SCHEMBL16867576 | 0.95 | MEN1 (0.57) | MEN1KMT2AL3MBTL1PPARGPPARA | |
| SCHEMBL27653731 | 0.95 | MEN1 (0.57) | MEN1KMT2AL3MBTL1PPARGPPARA | |
| SCHEMBL14733287 | 0.95 | MEN1 (0.57) | MEN1KMT2AL3MBTL1PPARGPPARA | |
| SCHEMBL1902134 | 0.92 | L3MBTL1 (0.55) | MEN1KMT2AL3MBTL1PPARGPPARA | |
| SCHEMBL28685324 | 0.92 | L3MBTL1 (0.55) | MEN1KMT2AL3MBTL1PPARGPPARA | |
| SCHEMBL14733296 | 0.90 | L3MBTL1 (0.51) | MEN1KMT2AL3MBTL1PPARGPPARA | |
| Ether SCHEMBL7704702 | 0.89 | MEN1 (0.51) | MEN1KMT2AL3MBTL1PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3207077-B1 | NEW BRANCHED POLYMERS, THEIR PREPARATION PROCESS, AND USES THEREOF | PIVERT (FR) | 2018-08-01 | — | — | EP | disclosed |
| US-20170306082-A1 | NEW BRANCHED POLYMERS, THEIR PREPARATION PROCESS, AND USES THEROF | PIVERT (FR) | 2017-10-26 | — | — | US | disclosed |
| US-20170306082-A1 | NEW BRANCHED POLYMERS, THEIR PREPARATION PROCESS, AND USES THEROF | PIVERT (FR) | 2017-10-26 | — | — | US | disclosed |
| WO-2016059230-A1 | NEW BRANCHED POLYMERS, THEIR PREPARATION PROCESS, AND USES THEREOF | PIVERT (FR) | 2016-04-21 | — | — | WO | disclosed |
| EP-3009464-A1 | New branched polymers, their preparation process, and uses thereof | Pivert (FR) | 2016-04-20 | — | — | EP | disclosed |
| US-8835663-B2 | Lubricity improver | KOREA INSTITUTE OF PETROLEUM MANAGEMENT (KR) | 2014-09-16 | — | — | US | disclosed |
| US-8835663-B2 | Lubricity improver | KOREA INSTITUTE OF PETROLEUM MANAGEMENT (KR) | 2014-09-16 | — | — | US | disclosed |
| US-20130053590-A1 | LUBRICITY IMPROVER | KOREA INSTITUTE OF PETROLEUM MANAGEMENT (KR) | 2013-02-28 | — | — | US | disclosed |
| US-20130053590-A1 | LUBRICITY IMPROVER | KOREA INSTITUTE OF PETROLEUM MANAGEMENT (KR) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053590-A1 | LUBRICITY IMPROVER | ELOVL1, ELOVL5, FASN | MEN1 3735/4885KMT2A 1954/4885L3MBTL1 3484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.